Feb 6, 2026
John Boozman- Amount
- $1,001 to $15,000
- Filed
- Mar 6, 2026
Congress ticker disclosure profile
As of August 1 at 7:10 PM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference EMB. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
10
Member filers
4
Disclosed ranges
$162K
Most active member desks
Balanced
Latest trade Feb 6, 2026
Feb 6, 2026
John BoozmanDec 7, 2018
Thomas MacarthurDec 7, 2018
Thomas MacarthurAug 1, 2018
Barbara J ComstockJun 13, 2018
Thomas MacarthurJun 13, 2018
Thomas MacarthurApr 25, 2018
Thomas MacarthurOct 12, 2017
Barbara J ComstockMay 31, 2017
Thomas MacarthurJan 9, 2015
Thad Cochran| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Feb 6, 2026 | John Boozman | Buy | $1,001 to $15,000 | Mar 6, 2026 | Open card |
| Dec 7, 2018 | Thomas Macarthur | Buy | $15,001 to $50,000 | Jan 11, 2019 | Open card |
| Dec 7, 2018 | Thomas Macarthur | Buy | $1,001 to $15,000 | Jan 11, 2019 | Open card |
| Aug 1, 2018 | Barbara J Comstock | Sell | Receipt pending ingestion | Aug 1, 2018 | Receipt pending ingestion |
| Jun 13, 2018 | Thomas Macarthur | Sell | $1,001 to $15,000 | Jul 10, 2018 | Open card |
| Jun 13, 2018 | Thomas Macarthur | Sell | $15,001 to $50,000 | Jul 10, 2018 | Open card |
| Apr 25, 2018 | Thomas Macarthur | Sell | $1,001 to $15,000 | May 10, 2018 | Open card |
| Oct 12, 2017 | Barbara J Comstock | Sell | $15,001 to $50,000 | Oct 13, 2017 | Open card |
| May 31, 2017 | Thomas Macarthur | Buy | $15,001 to $50,000 | Jun 17, 2017 | Open card |
| Jan 9, 2015 | Thad Cochran | Buy | Receipt pending ingestion | Jan 13, 2015 | Receipt pending ingestion |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 8 of 10 filed rows include disclosed amount ranges (80%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.